chr17-4897956-A-AGT
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The NM_153827.5(MINK1):c.*673_*674dupTG variant causes a 3 prime UTR change. The variant allele was found at a frequency of 0.000808 in 144,838 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00081 ( 1 hom., cov: 29)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
MINK1
NM_153827.5 3_prime_UTR
NM_153827.5 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.46
Publications
1 publications found
Genes affected
MINK1 (HGNC:17565): (misshapen like kinase 1) This gene encodes a serine/threonine kinase belonging to the germinal center kinase (GCK) family. The protein is structurally similar to the kinases that are related to NIK and may belong to a distinct subfamily of NIK-related kinases within the GCK family. Studies of the mouse homolog indicate an up-regulation of expression in the course of postnatal mouse cerebral development and activation of the cJun N-terminal kinase (JNK) and the p38 pathways. [provided by RefSeq, Mar 2016]
CHRNE (HGNC:1966): (cholinergic receptor nicotinic epsilon subunit) Acetylcholine receptors at mature mammalian neuromuscular junctions are pentameric protein complexes composed of four subunits in the ratio of two alpha subunits to one beta, one epsilon, and one delta subunit. The acetylcholine receptor changes subunit composition shortly after birth when the epsilon subunit replaces the gamma subunit seen in embryonic receptors. Mutations in the epsilon subunit are associated with congenital myasthenic syndrome. [provided by RefSeq, Sep 2009]
CHRNE Gene-Disease associations (from GenCC):
- congenital myasthenic syndromeInheritance: AR Classification: DEFINITIVE Submitted by: Illumina
- congenital myasthenic syndrome 4AInheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
- congenital myasthenic syndrome 4BInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
- congenital myasthenic syndrome 4CInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- postsynaptic congenital myasthenic syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000808 (117/144838) while in subpopulation EAS AF = 0.0219 (104/4756). AF 95% confidence interval is 0.0185. There are 1 homozygotes in GnomAd4. There are 59 alleles in the male GnomAd4 subpopulation. Median coverage is 29. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 117 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MINK1 | ENST00000355280.11 | c.*673_*674dupTG | 3_prime_UTR_variant | Exon 32 of 32 | 1 | NM_153827.5 | ENSP00000347427.6 | |||
CHRNE | ENST00000649488.2 | c.*778_*779dupAC | 3_prime_UTR_variant | Exon 12 of 12 | NM_000080.4 | ENSP00000497829.1 |
Frequencies
GnomAD3 genomes AF: 0.000808 AC: 117AN: 144726Hom.: 1 Cov.: 29 show subpopulations
GnomAD3 genomes
AF:
AC:
117
AN:
144726
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1766Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 864
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
1766
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
864
African (AFR)
AC:
0
AN:
0
American (AMR)
AF:
AC:
0
AN:
196
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
6
East Asian (EAS)
AF:
AC:
0
AN:
10
South Asian (SAS)
AF:
AC:
0
AN:
120
European-Finnish (FIN)
AF:
AC:
0
AN:
108
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
0
AN:
1260
Other (OTH)
AF:
AC:
0
AN:
66
GnomAD4 genome AF: 0.000808 AC: 117AN: 144838Hom.: 1 Cov.: 29 AF XY: 0.000840 AC XY: 59AN XY: 70250 show subpopulations
GnomAD4 genome
AF:
AC:
117
AN:
144838
Hom.:
Cov.:
29
AF XY:
AC XY:
59
AN XY:
70250
show subpopulations
African (AFR)
AF:
AC:
4
AN:
38216
American (AMR)
AF:
AC:
4
AN:
14244
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3416
East Asian (EAS)
AF:
AC:
104
AN:
4756
South Asian (SAS)
AF:
AC:
1
AN:
4464
European-Finnish (FIN)
AF:
AC:
0
AN:
9858
Middle Eastern (MID)
AF:
AC:
0
AN:
284
European-Non Finnish (NFE)
AF:
AC:
0
AN:
66736
Other (OTH)
AF:
AC:
4
AN:
1970
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
5
11
16
22
27
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
16
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Congenital Myasthenic Syndrome, Dominant/Recessive Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.